Novartis for example has European grants for researchers on a yearly theme. One of the conditions of the grant is that they have first right to licence. This has to be negotiated with the University Legal and Enterprise team as they hold the rights to any research on their premises and not the researchers.
Scientists, page-8
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$289.00 |
Change
-0.500(0.17%) |
Mkt cap ! $139.6B | |||
| Open | High | Low | Value | Volume |
| $289.00 | $289.94 | $287.13 | $142.9M | 494.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1048 | $288.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $289.12 | 7 | 1 |
View Market Depth
| Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$288.83 |
Change
-0.500 ( 0.44 %) |
||||
| Open | High | Low | Volume | ||
| $289.01 | $289.91 | $287.15 | 137116 | ||
| Last updated 15.59pm 07/06/2024 ? | |||||
| CSL (ASX) Chart |